Influenza A virus vaccine H5N1 (Novartis)

甲型流感病毒疫苗H5N1

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInfluenza A virus vaccine H5N1 (Novartis)
Drug Alias NameInfluenza A virus strain H5N1 vaccinePre-pandemic H5N1 influenza vaccinePre-pandemic influenza vaccineFlu Cell Culture H5N1Aflunov
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza A virus infectionsInfluenza in BirdsInfluenza, Human
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2010/11/28
Country/TerritoryUnited StatesPolandThailand +[8] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesSeqirus Srl
Inactive CompaniesSeqirusNovartis Pharma AgNovartis Vaccines
Active IndicationsInfluenza, Human
Inactive IndicationsInfluenza A virus infectionsInfluenza in Birds

Other Information

ATC CodeJ07BB02
Related LinksWikipediaKEGG